New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 26, 2023 - The FDA approved GSK’s Zejula (niraparib) tablets.
Download PDF
Return to publications
